US 11208650
Modulators of IRF5 expression
granted A61PA61P1/04
Quick answer
US patent 11208650 (Modulators of IRF5 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/04